Headlines
100 Years of Fashion Goes Red
Dr. Philip Adamson/Medical Journal Cardiologists
Dr. Carl Rubenstein/American Board of Clinical Lipidology
Latest Technology in Imaging Devices
2007 Heart Heroes Announced!
...read the dramatic stories of this year's recipients
Watch the Heart Hero Announcement Here
NEWS 9 Heart Hero Story #1
NEWS 9 Heart Hero Story #2
NEWS 9 Heart Hero Story #3
100 Years of Fashion Goes Red – Official Centennial Event –
Celebrated Valentine’s Day
OklahomaHeart Hospital and Oklahoma Cardiovascular Associates Celebrate “Wear Red” Campaign to Educate Oklahoma Women about
Risk of Heart Disease
February 14, 2007
OKLAHOMA CITY— The Oklahoma Heart Hospital and Oklahoma Cardiovascular Associates are celebrating Valentine’s Day and Wear Red month by inaugurating a new Centennial display at the hospital that honors Red Fashions through the decades of Oklahoma’s 100 years. The display will be celebrated on Valentine’s Day – the day of hearts.
“We are weaving our commitment to women’s heart health with the national “Wear Red” campaign and Oklahoma’s Centennial this year with a fabulous display of red dresses throughout the 100 year history of Oklahoma,” said Peggy Tipton, R.N., Chief Operating Officer, Oklahoma Heart Hospital. “Our team has searched for vintage dresses from across the country and designed and sewn antique dresses representing the 10 decades of Oklahoma’s Centennial.”
The Centennial dresses feature an outstanding woman from Oklahoma’s history representing each decade of the 100 years. The exhibit recognizes the famous Pioneer Woman from Ponca City – the flamboyant flapper of the Oil fields in the 20’s – the nation’s first black judge – the first female awarded a Purple Heart in World War II and many more notable Oklahoma women.
A compliment to the Centennial display is a display of red dresses donated by Oklahoma’s First Ladies. Donna Nigh will join the celebration, Cathy Keating will be on hand to tell her family’s personal story battling heart disease, and the daughters of Shirley Bellmon will talk about the impact of their mother’s death to heart disease on that family. NBA Hornet forward Marc Jackson will present a specially made red Hornets uniform to the exhibit during the event to honor women with heart disease.
“The facts of women’s heart disease in Oklahoma continue to shock us, the average age for heart disease among Oklahoma women is 49 years old. Heart disease is the #1 killer of women – taking more Oklahoma women’s lives than all of the cancers combined, 1 in 3 women in our state will develop heart disease. And yet a recent Harris poll revealed only 13 percent of women in America believes that heart disease and stroke are the greatest health threat to women.” – Dr. John Harvey, Chief Executive Officer, Oklahoma Heart Hospital.
THE HEART TRUTH IS:
One in three women dies of heart disease. One in 30 dies of cancer.
Nearly two-thirds of American women who die suddenly of a heart attack had no prior symptoms.
Two-thirds of American women who have had a heart attack don’t make a full recovery.
American women can lower their risk of heart disease by as much as 82 percent by leading a healthy lifestyle.
OKLAHOMAWOMEN FACTS
Heart disease is the number one killer of Oklahoma women
Oklahoma women rank third in the nation in rate of heart disease
51% of heart attack deaths in Oklahoma are in women (2003)
80,000 Oklahoma women hospitalized with heart disease (2001)
Average Oklahoman woman’s age for heart disease is 49 years old
Oklahoma has third highest smoking rate in America
Diabetes has increased 43% in past decade in Oklahoma
One in 5 Oklahomans has high blood pressure
One in 5 Oklahomans has high cholesterol
PREVENTION
Avoid smoking and environmental tobacco smoke
30 minutes of exercise on most days
Control diabetes
Heart-healthy diet including a variety of fruits and vegetables, grains, low-fat or no-fat dairy products, fish, legumes and proteins low in saturated fat
Watch your weight
Maintain a blood pressure less than 120/80
Control cholesterol …LDL higher than 100 mg
HDL lower than 50 mg
Triglycerides lower than 150 mg
Oklahoma Cardiovascular Associatesis the states largest group of cardiovascular specialists with 40 physicians in nearly 40 clinics across Oklahoma, including the Oklahoma Heart Hospital. ocaheart.com
The Oklahoma Heart Hospital is the state’s first all-digital hospital totally focused on the care of hearts.
For the location nearest you call 888-777-3818. okheart.com
Back To Top
Oklahoma Cardiovascular Associates’ Dr. Philip Adamson Named to Editorial Board of Medical Journal for Cardiologists
OKLAHOMA CITY—Oklahoma Cardiovascular Associates today announced that nationally honored heart failure expert and cardiologist Dr. Philip Adamson has been named to the Editorial Board of Congestive Heart Failure, a publication serving specialists and primary care clinicians treating heart failure. Congestive Heart Failure features manuscripts and papers on the prevention and management of congestive heart failure. As a member of the Editorial Board, Adamson will participate in the selection of articles and studies to be included in each issue of the journal.
Dr. Adamson is medical director of the Heart Failure Institute at Oklahoma Heart Hospital and is an Associate Professor of Physiology and Cardiology at the University of Oklahoma Health Sciences Center in Oklahoma City. Dr. Adamson is also a member of the American Board of Internal Medicine and the American Board of Internal Medicine – Cardiovascular Disease. He is the author of a number of ground-breaking scientific papers regarding advancements in the treatment and management of congestive heart failure. Dr. Adamson is frequently invited as a speaker at national and international cardiology symposiums with an emphasis on heart failure.
Congestive Heart Failureis a bimonthly, peer reviewed medical journal circulated to over 22,000 cardiologists specializing in the diagnosis and treatment of heart failure. Indexed in Index Medicus and available on Medline, the publication is recognized as a leading resource for clinicians and cardiologists pursuing the latest advances in the treatment or prevention of congestive heart failure. Congestive Heart Failure is founded on the editorial premise that successful education of primary care providers in the diagnosis and treatment of congestive heart failure will establish standards of care that can be measured and correlated with clinical outcomes. As a peer-reviewed journal, the publication depends on the knowledge and discernment of its editorial board to dictate which articles will ultimately influence the direction of treatment and diagnosis of the disease.
The most recent issue of Congestive Heart Failure features a paper written by Dr. Adamson and collegues detailing the latest data culminating from a worldwide investigation into use of ambulatory hemodynamic monitoring from implanted devices in patients with heart failure. Dr. Adamson’s team assessed the value of information collected by the hemodynamic monitor in tracking and reporting a patient’s fluid volumes and pressures. Such studies may ultimately bring the experimental device into more standard medical practice for heart failure patients.
Oklahoma Cardiovascular Associates is the state’s largest group of cardiovascular specialists with 39 physicians in nearly 40 clinics across Oklahoma, including the Oklahoma Heart Hospital. The Oklahoma Heart Hospital is one of the nation’s first all-digital hospitals totally focused on heart care. For the location nearest you call 888-777-3818. ocaheart.com
Back To Top
Oklahoma Cardiovascular Associates’ Dr. Carl Rubenstein Distinguished as Diplomat with the American Board of Clinical Lipidology
OklahomaExpert Becomes One of the First Physicians Nationwide in New Medical Field
OKLAHOMA CITY—Cardiologist Dr. Carl Rubenstein has been awarded the distinction of Diplomat by the American Board of Clinical Lipidology (ABCL), making him one of the first in the nation to be board certified in the emerging medical specialty of Clinical Lipidology.
Dr. Rubenstein is a cardiologist in private practice with Oklahoma Cardiovascular Associates (OCA), the state’s largest group of cardiovascular specialists in association with the Oklahoma Heart Hospital. Rubenstein is Clinical Professor of Medicine at the University of Oklahoma Health Sciences Center and a national expert in the preventive aspect of cardiovascular care, particularly the study of the impact of lipids or fat in the bloodstream. Dr. Rubenstein has been a researcher in many lipid trials including the Coronary Primary Prevention Trial (CCPT), as well as numerous other lipid-lowering research activities.
The American Board of Clinical Lipidology (ABCL) is an independent certifying organization offering the first and only certification program for physicians specializing in Clinical Lipidology. The ABCL has established a rigorous credentialing process and examination that will assess and validate the specialized knowledge and advanced training required to practice in the dynamic and complex field of lipidology.
Lipids refer to a diverse range of molecules, and to some extent it is a catch-all for relatively water-insoluble compounds including liquid fats and oils. Lipidology is the study of the effects of fats in the body, including levels of cholesterol and triglycerides. “We are just beginning to understand the complexity of the effect of lipids in the human body, it certainly is a segment of medicine that deserves more study and specialization,” noted Dr. Rubenstein. “I am thrilled to be part of the first wave of recognized specialists in this growing and diverse field.”
Dr. Rubenstein met very rigorous eligibility requirements to be named a Diplomat with the American Board of Clinical Lipidology. Diplomats must have advanced training and education, experience, and usually an academic appointment or clinical research in the field of lipid disorders.
Dr. Rubenstein joined OCA in 1996 and is a Clinical Professor of Medicine at the University of Oklahoma. Dr. Rubenstein was the Chairman of the Cardiovascular Committee of Lipid Research Centers Programs of the NIH from 1973-1983. He has multiple publications and lectures on lipid disorders and heart disease. He was a full time faculty member at the University of Oklahoma Department of Medicine from 1972-1982. He was an Associate Member of the Oklahoma Medical Research Foundation from 1972-1983. From 1993-1995, he was the Vice-Chairman of the Department of Medicine at the Presbyterian Hospital in Oklahoma City, Oklahoma, and from 1995-1998, he served as the Chairman. He started the Cardiac Rehabilitation Program at the Presbyterian Hospital in 1979, and was its Medical Director until 2002. Dr. Rubenstein currently is Medical Director of the Cardiac Rehabilitation Program for Mercy Health Center and the Oklahoma Heart Hospital.
About the American Board of Clinical Lipidology:
The ABCL was incorporated in 2003 as a private, not-for-profit corporation. Board members are elected by the Board of Directors and serve three-year terms. Primary goals of the Board are to establish lipidology as an independent medical specialty and help build a foundation of educational opportunities that will provide lipid specialists with the ability to advance their professional development, validate their knowledge and advanced training in the field, and ultimately, allow them to demonstrate their commitment to lipidology by obtaining certification as a clinical lipid specialist.
Oklahoma Cardiovascular Associates is the state’s largest group of cardiovascular specialists with 39 physicians in nearly 40 clinics across Oklahoma, including the Oklahoma Heart Hospital. The Oklahoma Heart Hospital is one of the nation’s first all-digital hospitals totally focused on heart care. For the location nearest you call 888-777-3818. ocaheart.com
Back To Top
LATEST TECHNOLOGY IN IMAGING DEVICES INCREASING NON-INVASIVE DIAGNOSTIC CAPABILITY
New Cardiac 64-slice CT and Cardiovascular Positron Emission Tomography Scanners Employed at Oklahoma Heart Hospital
OKLAHOMA CITY—The Oklahoma Heart Hospital and Oklahoma Cardiovascular Associates (OCA) have combined resources to bring their patients the latest technology in imaging diagnostics with the addition of a cardiac Positron Emission Tomography (PET) scanner and the newest state-of-the-art 64-slice computed tomography (CT) scanner.
"The 64-slice CT scanner has revolutionized cardiovascular medicine by allowing the cardiologist to image and “see” the coronary arteries around the heart with the same high quality and clarity as a more invasive heart catheterization procedure,” said Dr. Leslie Oberst, Director of the Cardiovascular CT Department at the Oklahoma Heart Hospital. “People inherently have risk factors, but up to this time, with the exception of cardiac catherization, we have not been able to pick up these high risk groups noninvasively. I see this test replacing much of the standard stress tests and routine cardiac catherization we are doing today."
The breakthrough technology of the 64-slice CT enables coronary artery disease to be diagnosed much earlier when vessels are narrowed about 20% to 30%. The majority of heart attacks occur suddenly from coronary blockages less than 50% and involving one artery. Most standard stress test imaging offered today can only pick up severe blockages of the coronary arteries. Mild to moderate blockages go undiagnosed.
The 64-slice CT is a virtually pain-free test that offers clear, detailed, high-quality images of the heart and can image other problems such as aortic aneurysm, andblockages in the arteries of the brain and lower extremities.
Oklahoma Heart Hospital’s Cardiac PET Scanner First in the Region
“Positron Emission Tomography is rapidly becoming a major imaging diagnostic tool for cardiovascular disease”, noted Dr. Carolyn Corn, Director of Nuclear Cardiology at OCA. “The PET/CT scan is used in two ways: First, it can detect areas of reduced blood flow in the heart from narrowed arteries. Second, it can differentiate between heart muscle that is scar tissue and heart muscle that is damaged but may still benefit from intervention with medications or other procedures.
PET is different from MRI (magnetic resonance imaging) and CT because it measures the metabolic process or chemistry of the tissues in and around the heart, as opposed to simply “seeing” the structure of the heart. PET images the function of the heart muscle rather than the structure of the heart.
A radiopharmaceutical or radioactive tracer is injected, via an IV, and the gamma ray emissions of the tracer are measured by the PET scanner’s array of detectors.
A CTscan is then superimposed on the data to correct for common sources of artifact such as breast implants, obesity, or lung disease. A computer analyzes the data and presents it in images that can be interpreted by the cardiovascular imaging specialist. The data gives images of blood flow and information about the pump function of the heart both at rest and during stress.
Medicare is now covering the 64-slice coronary CT scan; however, private insurance coverage is varied based on the individual insurance company. Universal coverage is expected soon, because once Medicare covers a procedure the insurance companies typically follow. The test costs between $900 to $1500, much less than other current diagnostic tests.
The 64-slice CT is a diagnostic test and not a screening test, therefore a physician must order this test. The patient must have a doctor to follow up on the test results and offer treatment options as needed. For those who do not have a primary physician to consult but still believe their symptoms warrant the test, they can be seen on an per case basis by calling and scheduling an appointment with Dr. Oberst at (405) 608-1664.
Oklahoma Cardiovascular Associatesis the state’s largest group of cardiovascular specialists with 39 physicians in nearly 40 clinics across Oklahoma, including the Oklahoma Heart Hospital. ocaheart.com
The Oklahoma Heart Hospital is the state’s first all-digital hospital totally focused on the care of hearts and the vascular system.
For the location nearest you call 888-777-3818. okheart.com
Back to Top